BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30551127)

  • 1. Effects of a single transient transfection of Ten-eleven translocation 1 catalytic domain on hepatocellular carcinoma.
    Liu Y; Zhu H; Zhang Z; Tu C; Yao D; Wen B; Jiang R; Li X; Yi P; Zhan J; Hu J; Ding J; Jiang L; Zhang F
    PLoS One; 2018; 13(12):e0207139. PubMed ID: 30551127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.
    Chuang KH; Whitney-Miller CL; Chu CY; Zhou Z; Dokus MK; Schmit S; Barry CT
    Hepatology; 2015 Aug; 62(2):466-80. PubMed ID: 25820676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
    Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X
    Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.
    Shirai K; Nagae G; Seki M; Kudo Y; Kamio A; Hayashi A; Okabe A; Ota S; Tsutsumi S; Fujita T; Yamamoto S; Nakaki R; Kanki Y; Osawa T; Midorikawa Y; Tateishi K; Ichinose M; Aburatani H
    Cancer Sci; 2021 Jul; 112(7):2855-2869. PubMed ID: 33970549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BACH1 is transcriptionally inhibited by TET1 in hepatocellular carcinoma in a microRNA-34a-dependent manner to regulate autophagy and inflammation.
    Sun X; Zhu H; Cao R; Zhang J; Wang X
    Pharmacol Res; 2021 Jul; 169():105611. PubMed ID: 33878446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis.
    Chen Q; Yin D; Zhang Y; Yu L; Li XD; Zhou ZJ; Zhou SL; Gao DM; Hu J; Jin C; Wang Z; Shi YH; Cao Y; Fan J; Dai Z; Zhou J
    Cell Death Dis; 2017 Jun; 8(6):e2906. PubMed ID: 28661477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.
    Tao QF; Yuan SX; Yang F; Yang S; Yang Y; Yuan JH; Wang ZG; Xu QG; Lin KY; Cai J; Yu J; Huang WL; Teng XL; Zhou CC; Wang F; Sun SH; Zhou WP
    Mol Cancer; 2015 Sep; 14():170. PubMed ID: 26376879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
    Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
    BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
    Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
    Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
    Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
    Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
    Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
    J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway.
    Guo H; Zhu H; Zhang J; Wan B; Shen Z
    J Cell Biochem; 2019 Aug; 120(8):12559-12565. PubMed ID: 30825236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.
    Wang W; Li X; Wang F; Sun XY
    J Cell Biochem; 2018 Jan; 119(1):723-735. PubMed ID: 28643947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
    Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target.
    Chen LY; Huang RL; Chan MW; Yan PS; Huang TS; Wu RC; Suryo Rahmanto Y; Su PH; Weng YC; Chou JL; Chao TK; Wang YC; Shih IM; Lai HC
    J Pathol; 2019 Jul; 248(3):363-376. PubMed ID: 30883733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of TET1-dependent DNA demethylation is essential for KRAS-mediated transformation.
    Wu BK; Brenner C
    Cell Rep; 2014 Dec; 9(5):1827-1840. PubMed ID: 25466250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.
    Wang K; Chen Z; Shi J; Feng Y; Yu M; Sun Y; Zhuang Q; Liang B; Luo G; Xu X; Fan M
    Prostate; 2020 Sep; 80(12):977-985. PubMed ID: 32542727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted TET oxidase activity through methyl-CpG-binding domain extensively suppresses cancer cell proliferation.
    Mizuguchi Y; Saiki Y; Horii A; Fukushige S
    Cancer Med; 2016 Sep; 5(9):2522-33. PubMed ID: 27457352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-eleven translocation 1 functions as a mediator of SOD3 expression in human lung cancer A549 cells.
    Kamiya T; Nakahara R; Mori N; Hara H; Adachi T
    Free Radic Res; 2017 Mar; 51(3):329-336. PubMed ID: 28351182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Wen H; Ji T; Lin L; Cheng N; Zhu K; Cao L
    Mediators Inflamm; 2023; 2023():2664370. PubMed ID: 37181808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.